-
Paidamoyo Chipunza Senior Health Reporter— The National Aids Council (NAC) has introduced night HIV testing to cater for people who cannot get tested during the day for various reasons. NAC Harare provincial Aids coordinator Mr Adonijah Muzondiona said the programme known as “moonlight testing” was already reaping results, as evidenced by the number of HIV positive cases […]
-
Paidamoyo Chipunza Senior Health Reporter— Two out of 30 HIV-positive people on anti-retroviral therapy (ART) in Zimbabwe have shown signs of resistance to commonly used and most affordable drugs Efavirenz and Nevirapine, the World Health Organisation (WHO) has said.
-
Paidamoyo Chipunza Senior Health Reporter Over 80 percent of cancer cases are diagnosed at end stage in Zimbabwe, amid revelations that an average 5 000 new cases are recorded every year. Underfunding and information gaps are worsening the situation.
-
Sydney Kawadza Senior Features Writer The beauty of organising events in a farming area is that the whole community gets involved, assuring organisers of genuine support from the people.
-
-
Thandeka Moyo Bulawayo Bureau ZIMBABWE will soon start rolling out pre-exposure prophylaxis (PrEP) medication in selected districts in the country after adopting World Health Organisation (WHO) guidelines on HIV treatment and prevention.
-
Paidamoyo Chipunza : Senior Health Reporter Over 20 percent of Africans taking Efavirenz, a first line anti-retroviral drug used in the management of HIV and aids could be taking an overdose, a local scientist Professor Collen Masimirembwa has revealed. In an interview on his latest scientific development aimed at assessing the safety and